Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension.
暂无分享,去创建一个
E. Bedrick | J. Garcia | A. Makino | S. Black | E. Brittain | E. Austin | R. Vanderpool | A. Hemnes | Shripad A. Sinari | A. Desai | Joe G. N. Garcia | Balaji Natarajan | Parinita Dherange | Vineet Nair | F. Rischard | Lindsey Trutter | Kumar Patel | Morgan Whitaker | Jason X Yuan Md PhD | B. Natarajan
[1] J. Wild,et al. Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension , 2017, American journal of respiratory and critical care medicine.
[2] A. Makino,et al. Hypoxia-induced pulmonary hypertension in type 2 diabetic mice , 2017, Pulmonary circulation.
[3] R. Tuder,et al. Pulmonary vascular remodeling in pulmonary hypertension , 2016, Cell and Tissue Research.
[4] J. Fritz,et al. The Pulmonary Hypertension Consult: Clinical and Coding Considerations. , 2016, Chest.
[5] R. Oudiz. Classification of Pulmonary Hypertension. , 2016, Cardiology clinics.
[6] A. Chawla,et al. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? , 2016, Indian journal of endocrinology and metabolism.
[7] D. Grinnan,et al. The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial Hypertension , 2016, Journal of diabetes research.
[8] L. Wilson,et al. The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions , 2016, Sports Medicine.
[9] O. Rimoldi,et al. From Left Ventricular Hypertrophy to Dysfunction and Failure. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[10] M. Gladwin,et al. SIRT3–AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction , 2016, Circulation.
[11] E. K. Weir,et al. The Critical Role of Pulmonary Arterial Compliance in Pulmonary Hypertension. , 2016, Annals of the American Thoracic Society.
[12] A. Hemnes,et al. Fatty Acid Metabolism in Pulmonary Arterial Hypertension: Role in Right Ventricular Dysfunction and Hypertrophy , 2015, Pulmonary circulation.
[13] S. Archer,et al. Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part I Metabolic Plasticity and Mitochondrial Dynamics in the Pulmonary Circulation and Right Ventricle in Pulmonary Arterial Hypertension , 2015, Circulation.
[14] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.
[15] C. Liang,et al. Impaired Right Ventricular Hemodynamics Indicate Preclinical Pulmonary Hypertension in Patients With Metabolic Syndrome , 2015, Journal of the American Heart Association.
[16] E. Brittain,et al. Impact of Diabetes on Survival and Right Ventricular Compensation in Pulmonary Arterial Hypertension , 2014, Pulmonary circulation.
[17] R. Gillum,et al. Trends in Pulmonary Hypertension Mortality and Morbidity , 2014, Pulmonary medicine.
[18] S. Archer. Mitochondrial fission and fusion in human diseases. , 2014, The New England journal of medicine.
[19] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[20] Ami A. Shah,et al. Right Ventricular Dysfunction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension , 2013, Circulation. Heart failure.
[21] J. Loscalzo,et al. Pulmonary hypertension: pathophysiology and signaling pathways. , 2013, Handbook of experimental pharmacology.
[22] Mario J. Garcia,et al. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. , 2012, JACC. Cardiovascular imaging.
[23] S. Archer,et al. Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.
[24] R. Machado,et al. Diagnostic and therapeutic algorithm for pulmonary arterial hypertension , 2011, Pulmonary circulation.
[25] T. Rice,et al. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[26] N. Westerhof,et al. The arterial load in pulmonary hypertension , 2010, European Respiratory Review.
[27] N. Hamburg,et al. Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications , 2010, Reviews in Endocrine and Metabolic Disorders.
[28] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[29] P. Thistlethwaite,et al. Development and pathology of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[30] Hadley Wickham,et al. Reshaping Data with the reshape Package , 2007 .
[31] Paul Sorajja,et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. , 2006, Journal of the American College of Cardiology.
[32] F. Messerli,et al. Diabetes, hypertension, and cardiovascular disease: an update. , 2001, Hypertension.
[33] E. Frohlich,et al. Diabetes, Hypertension, and Cardiovascular Disease: An Update , 2001, Hypertension.
[34] J E Tooke,et al. Microvascular Function in Human Diabetes: A Physiological Perspective , 1995, Diabetes.